Clinical Trials
2 trialsNCT06997068 2026-05-11
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Mayo Clinic
Phase 2 Recruiting
NCT07020117 2026-04-21
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Aktis Oncology, Inc.
Phase 1 Recruiting